ConductScience.org, home

Paper7206587

Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.

Eichelbaum M and 4 others. Klin Wochenschr, 1980. Cited by 114 papers, by iCite.

Cite this record

ConductScience Library. Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment. Papers, record 7206587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7206587

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.
PubMed
Journal
Klin Wochenschr
PubMed
Year
1980
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
114
iCite
Relative citation ratio, by iCite
7.2
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eichelbaum MM
2Birkel PP
3Grube EE
4Gütgemann UU
5Somogyi AA

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ElectrocardiographyMajor topic
VerapamilMajor topic
Administration, Oral
Adult
Female
Humans
Infusions, Parenteral
Male

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17248141Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7248141PubMed
2954350Relationship between the pharmacokinetics and pharmacodynamics of procainamide.Clin Pharmacol Ther1976https://conductscience.org/library/papers/954350PubMed
3576822Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard.Arzneimittelforschung1977https://conductscience.org/library/papers/576822PubMed
47202472Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7202472PubMed
51004639Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil.Naunyn Schmiedebergs Arch Pharmacol1976https://conductscience.org/library/papers/1004639PubMed
6461970Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.Res Commun Chem Pathol Pharmacol1979https://conductscience.org/library/papers/461970PubMed
738084The metabolism of DL-[14C]verapamil in man.Drug Metab Dispos1979https://conductscience.org/library/papers/38084PubMed
8971476Physiological disposition of verapamil in man.Cardiovasc Res1976https://conductscience.org/library/papers/971476PubMed
9805050Assessment of verapamil in the treatment of angina pectoris.Eur J Cardiol1975https://conductscience.org/library/papers/805050PubMed
101091129Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.Am Heart J1975https://conductscience.org/library/papers/1091129PubMed
117202473Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7202473PubMed
124196671[Physiology and pharmacology of sodium, potassium, and calcium movements across the membrane].Arzneimittelforschung1972https://conductscience.org/library/papers/4196671PubMed
135814829[A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].Pflugers Arch1969https://conductscience.org/library/papers/5814829PubMed
14657182Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.Cardiovasc Res1978https://conductscience.org/library/papers/657182PubMed
154098332[Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].Arzneimittelforschung1970https://conductscience.org/library/papers/4098332PubMed
16432439Pharmacokinetics of verapamil in man.Res Commun Chem Pathol Pharmacol1979https://conductscience.org/library/papers/432439PubMed
17346345Verapamil: a review of its pharmacological properties and therapeutic use.Drugs1978https://conductscience.org/library/papers/346345PubMed

Download CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.

PMIDTitleJournalYearIn PapersSource
32210283The cardiac work-loop technique: An in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles.Sci Rep2020https://conductscience.org/library/papers/32210283PubMed
12102640Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.Clin Pharmacokinet2002https://conductscience.org/library/papers/12102640PubMed
10336579Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil.Br J Clin Pharmacol1999https://conductscience.org/library/papers/10336579PubMed
9474531New mathematical implementation of generalized pharmacodynamic models: method and clinical evaluation.J Pharmacokinet Biopharm1997https://conductscience.org/library/papers/9474531PubMed
8261714Individual variation in first-pass metabolism.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261714PubMed
7248141Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7248141PubMed
7032803Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.Clin Pharmacokinet1981https://conductscience.org/library/papers/7032803PubMed
6721991Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6721991PubMed
6714292Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6714292PubMed
6538884Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.J Clin Invest1984https://conductscience.org/library/papers/6538884PubMed
6508982Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508982PubMed
6404580Reliability of antiarrhythmic drug plasma concentration monitoring.Clin Pharmacokinet1983https://conductscience.org/library/papers/6404580PubMed
6362951Clinical pharmacokinetics of verapamil.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362951PubMed
6362950First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362950PubMed
6339196Calcium antagonists. Pharmacokinetic properties.Drugs1983https://conductscience.org/library/papers/6339196PubMed
4065190Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4065190PubMed
3994898An investigation of the cause of accumulation of verapamil during regular dosing in patients.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3994898PubMed
3986090Verapamil disposition--effects of sulphinpyrazone and cimetidine.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3986090PubMed
3905334Importance of drug enantiomers in clinical pharmacology.Drugs1985https://conductscience.org/library/papers/3905334PubMed
3756058Pharmacokinetics of conventional and slow-release verapamil.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3756058PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7206587

GET https://conductscience.org/api/papers/v1/7206587/cited_by?page=2